AstraZeneca has announced promising results from the BATURA Phase IIIb trial, showcasing the effectiveness of AIRSUPRA ...

Summary: Nebulization is gaining popularity as a treatment alternative ... Nebulized magnesium sulfate can be used in managing acute asthma and is given in dosages between 125 and 250 mg every ...

It is a severe, whole-body reaction that requires immediate medical attention. Anaphylaxis can occur when a person’s immune ...

An initial list of 101 generic drugs available to those enrolled in the government's Medicare program for no more than $2 for ...

The U.S. Centers for Medicare & Medicaid Services (CMS) has released a preliminary list of 101 generic drugs that would be ...

Treatment with oral or inhaled corticosteroids is not warranted for children without history of atopy or family history of asthma ... received albuterol plus a 7-day course of inhaled budesonide ...

The global airway disease treatment market is projected to experience significant growth over the next decade, with revenue ...

The Biden administration has reformed Medicare, gone after bogus drug patents and pushed pharmaceutical companies to reduce ...

but the at-risk patient may be recognised on the basis of prior ICU admission and asthma medication history. Patients who fail to improve significantly in the emergency department should be admitted ...

AZ’s Airsupra (albuterol and budesonide) – developed with Avillion – was approved by the FDA last year for as-needed treatment or prevention of asthma symptoms and to help prevent asthma ...

Israel-based Teva said the system conveys information to patients, who can use the product branded as ProAir Digihaler (albuterol sulfate) for patients with asthma and chronic obstructive ...